Scinai Immunotherapeutics (SCNI) Change in Cash (2018 - 2026)

Scinai Immunotherapeutics (SCNI) has 9 years of Change in Cash data on file, last reported at $1.3 million in Q1 2026.

• For the quarter ending Q1 2026, Change in Cash rose 237.74% year-over-year to $1.3 million; the trailing twelve-month figure through Mar 2026 stood at $1.3 million (up 133.14% YoY), and the FY2025 full-year result was -$284000.0, up 90.26% from the prior year.
• Change in Cash climbed to $1.3 million in Q1 2026, from -$18000.0 in the prior quarter.
• In the past five years, Change in Cash ranged from a high of $5.8 million in Q4 2022 to a low of -$9.3 million in Q2 2022.
• A 5-year average of -$1.4 million and a median of -$1.5 million in 2023 frame the typical range for Change in Cash.
• Across the five-year window, Change in Cash tumbled 2050.0% in 2025 and jumped 237.74% in 2026, its largest moves.
• Tracing SCNI's Change in Cash over 5 years: stood at $5.8 million in 2022, then plunged by 125.56% to -$1.5 million in 2023, then surged by 162.86% to $926000.0 in 2024, then sank by 101.94% to -$18000.0 in 2025, then surged by 7338.89% to $1.3 million in 2026.
• Business Quant data shows SCNI's Change in Cash at $1.3 million in Q1 2026, -$18000.0 in Q2 2025, and -$946000.0 in Q1 2025.